🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 826917106
- Market Cap
- Small Cap · $387 Million
- Previous Symbol
- SIGA (changed 3/20/2015)
- Previous Name
- SIGA Pharmaceuticals, Inc.
Business: SIGA Technologies is a pharmaceutical company specializing in developing therapeutic solutions for some of the most lethal disease-causing pathogens - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Their business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high-priority threats. Their mission is to create robust, modern countermeasures to dreaded viral diseases.
Notes: March 18, 2015 -- The Company announced that it received a letter today from the Hearings Advisor for The NASDAQ Stock Market LLC ("NASDAQ"), indicating that the NASDAQ Hearings Panel has determined to delist the shares of the Company from the NASDAQ Stock Market and accordingly, suspend trading in the Company's shares effective at the open of business on March 20, 2015. SIGA expects its shares to continue to trade on the OTC Markets under the "SIGAQ" symbol.
Company Contact
- CEO
- Eric A. Rose, M.D.
- CFO
- Daniel J. Luckshire
- Headquarters
- 35 East 62nd Street, New York, NY 10065
- Phone
- 212-672-9100
- Fax
- 212-896-1236
- Investor Relations
- Todd Fromer · 212-896-1215 · Tfromer@kcsa.com